Belatacept | Interleukin Related interleukin-related.com

Product Name :
Belatacept

Search keywords :
Belatacept

drugId :
null

Target Vo:
Cluster of differentiation 80

Target Vo Short Name :
CD80

Moa_Name:
Cluster of differentiation 86 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2011

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :
Brigham and Women’s Hospital Inc

Active Indication_Name:
Rejection of renal transplantation

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AKT1 (Ser473) Antibody
Acetyl CoA Carboxylase 1 (ACC1) Antibody
HMGCS2 Antibody: HMGCS2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to HMGCS2. It can be used for WB, IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts